Why the study?
Does influenza vaccination reduce the risk of death and ischaemic events in patients with acute coronary syndromes and planned percutaneous coronary interventions?
Does influenza vaccination reduce the risk of death and ischaemic events in patients with acute coronary syndromes and planned percutaneous coronary interventions?
Influenza vaccination may significantly reduce the risk of death and ischemic events at 1 year in patients with acute coronary syndromes or undergoing planned PCI.
May support vaccination in ACS/PCI patients; leaves open confirmation in randomized trials.
Influenza vaccination may reduce the risk of death and ischaemic events in patients suffering from infarction and post-angioplasty during flu season. This effect was significantly evident at 1-year follow-up. Larger confirmatory studies are needed to evaluate the real impact on flu vaccination on outcome after acute coronary syndromes.
No takes yet. Share an insight, caveat, or question.
Enrique Gurfinkel (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: